Zobrazeno 1 - 10
of 55
pro vyhledávání: '"Hélène, Bachelard"'
Autor:
François Marceau, Georges-Etienne Rivard, Jacques Hébert, Julie Gauthier, Hélène Bachelard, Tanja Gangnus, Bjoern B. Burckhardt
Publikováno v:
Frontiers in Allergy, Vol 3 (2022)
BackgroundHereditary angioedema (HAE) is a rare autosomal dominant disease; the most well understood forms concern the haplodeficiency of C1 esterase inhibitor (C1INH) and a gain of function mutation of factor XII (FXII). The acute forms of these con
Externí odkaz:
https://doaj.org/article/d6d6984eeddc4df18e7c64ca05824963
Publikováno v:
BMC Research Notes, Vol 12, Iss 1, Pp 1-6 (2019)
Abstract Objective We recently investigated the pathways of immunoreactive bradykinin (iBK) formation in fresh blood of normal volunteers and of patients with hereditary angioedema due to C1-esterase inhibitor deficiency (HAE-1/-2). Herein, we adapte
Externí odkaz:
https://doaj.org/article/953d4ec9425f4130bcbfe9fb970da964
Autor:
François Marceau, Georges E. Rivard, Julie M. Gauthier, Karen E. Binkley, Arnaud Bonnefoy, Isabelle Boccon-Gibod, Laurence Bouillet, Matthieu Picard, Ghislain Levesque, Hannah Laure Elfassy, Hélène Bachelard, Jacques Hébert, Konrad Bork
Publikováno v:
Frontiers in Medicine, Vol 7 (2020)
Bradykinin (BK)-mediated angioedema (AE) states are rare acquired or hereditary conditions involving localized edema of the subcutaneous and submucosal tissues. Citrated plasma from healthy volunteers or patients with hereditary angioedema (HAE) with
Externí odkaz:
https://doaj.org/article/8214c6f93a4949ccbb088b8b53b02298
Autor:
François Marceau, Hélène Bachelard
Publikováno v:
Pharmaceuticals, Vol 14, Iss 3, p 177 (2021)
Bradykinin (BK) has various physiological and pathological roles. Medicinal chemistry efforts targeted toward the widely expressed BK B2 receptor (B2R), a G-protein-coupled receptor, were primarily aimed at developing antagonists. The only B2R antago
Externí odkaz:
https://doaj.org/article/c8da2586de2541ba8f75ca8f5b284ff9
Publikováno v:
Pharmaceuticals, Vol 13, Iss 9, p 201 (2020)
Kinins (peptides related to bradykinin, BK) are formed from circulating substrates, the kininogens, by the action of two proteases, the kallikreins. The only clinical application of a BK receptor ligand, the B2 receptor antagonist icatibant, is the t
Externí odkaz:
https://doaj.org/article/de7c23917d4747fbac219d2cbe676707
Publikováno v:
Frontiers in Pharmacology, Vol 9 (2018)
We previously reported hypotensive and vasodilator effects from C-terminally extended bradykinin (BK) sequences that behave as B2 receptor (B2R) agonists activated by vascular or plasma peptidases. D-Arg0-BK-Arg-Arg (r-BK-RR) is a novel prodrug pepti
Externí odkaz:
https://doaj.org/article/ec948c02ce484ffcbdfaa4461294ca16
Publikováno v:
PeerJ, Vol 5, p e2911 (2017)
Maximakinin (MK), an amphibian peptide possessing the C-terminal sequence of bradykinin (BK), is a BK B2 receptor (B2R) agonist eliciting prolonged signaling. We reinvestigated this 19-mer for species-specific pharmacologic profile, in vivo confirmat
Externí odkaz:
https://doaj.org/article/f06d2050ad614c879558085f9e1d9f52
Autor:
Hélène, Bachelard, François, Marceau
Publikováno v:
International immunopharmacology. 110
The centrally acting antitussive opiate derivative, noscapine, has been claimed to be a non-competitive bradykinin B
Publikováno v:
Pharmaceuticals
Pharmaceuticals, Vol 13, Iss 201, p 201 (2020)
Pharmaceuticals, Vol 13, Iss 201, p 201 (2020)
Kinins (peptides related to bradykinin, BK) are formed from circulating substrates, the kininogens, by the action of two proteases, the kallikreins. The only clinical application of a BK receptor ligand, the B2 receptor antagonist icatibant, is the t
Autor:
Jacques Hébert, Georges E. Rivard, Isabelle Boccon-Gibod, Hannah Laure Elfassy, Matthieu Picard, François Marceau, Laurence Bouillet, Arnaud Bonnefoy, Konrad Bork, Hélène Bachelard, Julie Gauthier, Karen Binkley, Ghislain Levesque
Publikováno v:
Frontiers in Medicine, Vol 7 (2020)
Frontiers in Medicine
Frontiers in Medicine
Bradykinin (BK)-mediated angioedema (AE) states are rare acquired or hereditary conditions involving localized edema of the subcutaneous and submucosal tissues. Citrated plasma from healthy volunteers or patients with hereditary angioedema (HAE) with